
Replacement of in vivo Immunogenicity Assay with in vitro Antigenicity ELISA for Pertactin Antigen in Acellular Pertussis Combination Vaccines

Speaker Presentation: WCBP 2025
Ljutic Belma, Sanofi, 2025
Replacement of in vivo Immunogenicity Assay with
in vitro Antigenicity ELISA
for Pertactin Antigen in
Acellular Pertussis
Combination Vaccines